Pushing the bounds of
ocular imaging.

We deliver visible-light optical coherence tomography technology, which offers the highest spatial resolution and imaging contrast in the market for clinical and preclinical use.

Leader Leader Leader Leader
Meet Opticent's Leaders →

Our Partners

We're trusted by industry leaders worldwide.

Performance

Market-Leading Precision.

Our vis-OCT technology redefined the limits of axial resolution and imaging speed. Explore the core specifications that power our clinical and research platforms.

Axial Resolution
1.3 μm

Unprecedented clarity in tissue imaging, nearly 3x higher than current state-of-the-art clinical OCTs.

Scanning Angle
56°

Wide-field coverage extending to the pupil pivotal point for comprehensive retinal diagnostics.

A-Line Rate
125 KHz

Ultra-fast acquisition speeds powered by our flagship Blizzard spectrometer for rapid alignment.

Our Products

We Develop Imaging Tools

Our tools aide top specialists in human clinical research, small animal ophthalmic research, metrology, and high performance spectrometry.
Put simply, our experts can fulfill your imaging needs.

Opticent Products

Leadership

Meet the Pioneers

Leader 1

Hao F. Zhang, Ph.D.

CHAIR OF THE BOARD, CO-FOUNDER

Professor of Biomedical Engineering and Ophthalmology at Northwestern University and co-inventor of Opticent's core technologies. As an R&D lead, he coordinates novel ophthalmologic imaging research and product development. Dr. Zhang holds a Ph.D. from Texas A&M, brings extensive expertise in biomedical optics and OCT, and has earned prestigious accolades including the NIH IMPACT award and the NAS Cozzarelli Prize.

Leader 2

Cheng Sun, Ph.D.

CO-FOUNDER

Professor of Mechanical Engineering at Northwestern University and co-inventor of Opticent's core technologies. With over a decade of expertise in optics and advanced manufacturing, Dr. Sun co-leads R&D efforts in ophthalmic imaging research, product development, and grant acquisition. He holds a Ph.D. from Pennsylvania State University and concurrently directs pioneering, NSF-funded nanophotonics research at Northwestern.

Leader 3

Joel S. Schuman, M.D.

BOARD MEMBER

Dr. Schuman leads the Advanced Ophthalmic Imaging Laboratory (AOIL), directing a multidisciplinary team of ophthalmologists, experts, software specialists, and statisticians. His research primarily focuses on the study of glaucoma, a leading cause of global blindness. He and his colleagues pioneer the development of advanced imaging tools designed to accurately diagnose this debilitating disease, monitor its progression, and investigate its underlying pathogenesis.

Leader 4

Nicholas J. Volpe, M.D.

BOARD MEMBER

Professor and Chairman of the Department of Ophthalmology at Northwestern University’s Feinberg School of Medicine. Earning his credentials at Harvard Medical School, Dr. Volpe transformed Northwestern’s department into a premier research institution. His clinical and research interests include neuro-ophthalmic disorders, vis-OCT, and optic nerve disease. He serves on numerous boards, including the American Ophthalmological Society and the Heed Foundation.